The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Stimulation of Bone Formation in Vitro and in Rodents by Statins
Abstract
Osteoporosis and other diseases of bone loss are a major public health problem. Here it is shown that the statins, drugs widely used for lowering serum cholesterol, also enhance new bone formation in vitro and in rodents. This effect was associated with increased expression of the bone morphogenetic protein–2 ( BMP-2 ) gene in bone cells. Lovastatin and simvastatin increased bone formation when injected subcutaneously over the calvaria of mice and increased cancellous bone volume when orally administered to rats. Thus, in appropriate doses, statins may have therapeutic applications for the treatment of osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Self-citationLaw, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Fisher, J. E., Rogers, M. J., Halasy, J. M., Luckman, S. P., Hughes, D. E., Masarachia, P. J., Wesolowski, G., Russell, R. G. G., Rodan, G. A., & Reszka, A. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.133 · Cited by 676
Perspectives: How many women have osteoporosis now?
Dr. Melton, J. L. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100202 · Cited by 595
Gowen, M., & Mundy, G. R. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2478 · Cited by 476
Self-citationThe Value of Lowering Cholesterol after Myocardial Infarction
Rossouw, J. E., Lewis, B., & Rifkind, B. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010183231606 · Cited by 410
Effects of Interleukin-1 on Bone Turnover in Normal Mice*
BOYCE, B. F., AUFDEMORTE, T. B., GARRETT, I. R., YATES, A. J. P., & MUNDY, G. R. (1989) · Endocrinology · doi:10.1210/endo-125-3-1142 · Cited by 363
Self-citationRao, S., Porter, D. C., Chen, X., Herliczek, T., Lowe, M., & Keyomarsi, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7797 · Cited by 345
Harris, S. E., Bonewald, L. F., Harris, M. A., Sabatini, M., Dallas, S., Feng, J. Q., Ghosh-Choudhury, N., Wozney, J., & Mundy, G. R. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090611 · Cited by 325
Self-citationYates, A. J., Gutierrez, G. E., Smolens, P., Travis, P. S., Katz, M. S., Aufdemorte, T. B., Boyce, B. F., Hymer, T. K., Poser, J. W., & Mundy, G. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113406 · Cited by 268
Self-citationHypotensive Activity of Fibroblast Growth Factor
Cuevas, P., Carceller, F., Ortega, S., Zazo, M., Nieto, I., & Giménez-Gallego, G. (1991) · Science · doi:10.1126/science.1957172 · Cited by 244
In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice
Marcelli, C., Yates, A. J., & Dr. Mundy, G. R. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650051013 · Cited by 234
Chen, D., Harris, M. A., Rossini, G., Dunstan, C. R., Dallas, S. L., Feng, J. Q., Mundy, G. R., & Harris, S. E. (1997) · Calcified Tissue International · doi:10.1007/s002239900230 · Cited by 230
Self-citationInfusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice.
Sabatini, M., Boyce, B., Aufdemorte, T., Bonewald, L., & Mundy, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5235 · Cited by 216
Self-citationDr. Rogers, M. J., Chilton, K. M., Coxon, F. P., Lawry, J., Smith, M. O., Suri, S., & Russel, R. G. G. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111015 · Cited by 194
Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice
Ghosh‐Choudhury, N., Windle, J. J., Koop, B. A., Harris, M. A., Guerrero, D., Wozney, J. M., Mundy, G. R., & Harris, S. E. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536632 · Cited by 101
Self-citation5-Lipoxygenase Metabolites Inhibit Bone Formation in Vitro
Traianedes, K., Dallas, M. R., Garrett, I. R., et al. (1998) · Endocrinology · doi:10.1210/endo.139.7.6115 · Cited by 96
Cited by
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Periodontitis and cardiovascular diseases: Consensus report
Sanz, M., Marco del Castillo, A., Jepsen, S., Gonzalez‐Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13189 · Cited by 1,482
“, 2006) can promote bone formation (Garrett, Gutierrez, & Mundy, 2001; Liu et al., 2012; Mundy et al., 1999; Viereck et al., 2005), can inhibit matrix metalloproteinases (MMPs) (Koh et al.”
BackgroundPleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272
Metadata
- Authors
- Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M., & Gutierrez, G.
- Venue
- Science
- Published
- 1999-12-03
- Volume
- 286
- Issue
- 5446
- Pages
- 1946-1949
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2020364703
- Cited by
- 1,774
- References
- 18
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.